They are developing bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions in the body.
Canadian Aspect Biosystems is one of the top global innovators in this field. They are developing bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions in the body. Most recently, in April 2023, they entered into a US$650M partnership to design disease-modifying treatments for diabetes and obesity.